引用次数
引用: 948
H-指数: 16
I10-指数 : 18
出版物: 37
TNFα/Grnd mediate JNK/MMPs activation during glioma progression and neurodegeneration
Marta Portela , Teresa Mitchell , Sergio Casas-Tintó
bioRxiv
2020
Tissue growth and tumorigenesis in Drosophila: cell polarity and the Hippo pathway
Helena E Richardson , Marta Portela
Current Opinion in Cell Biology 48 1 -9
36
2017
Oncogenic dependence of glioma cells on kish/TMEM167A regulation of vesicular trafficking
Marta Portela , Berta Segura-Collar , Irene Argudo , Almudena Sáiz
Glia 67 ( 2) 404 -417
10
2019
Lgl reduces endosomal vesicle acidification and Notch signaling by promoting the interaction between Vap33 and the V-ATPase complex
Marta Portela , Liu Yang , Sayantanee Paul , Xia Li
Science Signaling 11 ( 533)
7
2018
Widening the concept of oncogene
Sergio Casas-Tintó , Marta Portela , Alberto Ferrús
Aging 8 ( 10) 2262 -2263
2016
PTP61F mediates cell competition and mitigates tumorigenesis
John E La Marca , Lee F Willoughby , Kirsten Allan , Marta Portela
International Journal of Molecular Sciences 22 ( 23) 12732
3
2021
Zonisamide is an antiseizure drug chemically classified as a sulfonamide and unrelated to other antiseizure agents Menu
Marta Portela , Berta Segura-Collar , Irene Argudo , Almudena Sáiz
The Drosophila Tumour Suppressor Lgl and Vap33 activate the Hippo pathway by a dual mechanism, involving RtGEF/Git/Arf79F and inhibition of the V-ATPase.
Helena E Richardson , Marta Portela , Swastik Mukherjee , Sayantanee Paul
bioRxiv 2023.07. 10.548302 -2023.07. 10.548302
2023
The Drosophila tumour suppressor Lgl and Vap33 activate the Hippo pathway through a dual mechanism
Marta Portela , Swastik Mukherjee , Sayantanee Paul , John E La Marca
Journal of Cell Science 137 ( 4)
2024
Use of liquid biomarker thymidine kinase activity (TKa) to predict outcome and progression in patients with metastatic breast cancer (MBC) in the GEICAM/2014-12 FLIPPER trial.
Joan Albanell , Amy Williams , Maria Teresa Martínez , Hanna Ritzen
Journal of Clinical Oncology 42 ( 16_suppl) 1028 -1028
2024
Evaluating Ki67 and Oncotype DX Breast Recurrence Score during neoadjuvant treatment with letrozole/abemaciclib or chemotherapy in patients with highly proliferative HR+/HER2-breast cancer participating in the GEICAM CARABELA trial.
Angel Guerrero , Miguel Martin , Maria Eva Perez , Manuel Ruiz-Borrego
Journal of Clinical Oncology 42 ( 16_suppl) 576 -576
2024
Plasma mutational burden in PIK3CA and TP53 independently predicts early progression in patients with HR+/HER2-metastatic breast cancer (MBC) enrolled in the GEICAM/2014-12 FLIPPER trial.
Federico Gustavo Rojo Todo , Lara Meier , Maria Teresa Martínez , María Esteban López
Journal of Clinical Oncology 42 ( 16_suppl) 1029 -1029
2024
Tumor growth and metastasis in Drosophila: Polarity and the Hippo pathway
Helena E Richardson , Marta Portela
Cooperation of the BTB-Zinc finger protein, Abrupt, with cytoskeletal regulators in Drosophila epithelial tumorigenesis.
N. Turkel , M. Portela , C. Poon , J. Li
Biology Open 4 ( 8) 1024 -1039
5
2015
The co-regulator dNAB interacts with Brinker to eliminate cells with reduced Dpp signaling.
O. Ziv , Y. Suissa , H. Neuman , T. Dinur
Development 136 ( 7) 1137 -1145
18
2009
Persistent competition among stem cells and their daughters in the Drosophila ovary germline niche
C. Rhiner , B. Diaz , M. Portela , J. F. Poyatos
Development 136 ( 6) 995 -1006
94
2009
Cytonemes, Their Formation, Regulation, and Roles in Signaling and Communication in Tumorigenesis.
Casas-Tintó , Portela
International Journal of Molecular Sciences 20 ( 22) 5641
11
2019